These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3941286)

  • 1. Cyclosporine may eliminate the threat of overwhelming strongyloidiasis in immunosuppressed patients.
    Schad GA
    J Infect Dis; 1986 Jan; 153(1):178. PubMed ID: 3941286
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of strongyloides hyperinfection syndrome: a rheumatological point of view.
    Santiago M; Leitão B
    Eur J Intern Med; 2009 Dec; 20(8):744-8. PubMed ID: 19892301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strongyloides hyperinfection: a treatment dilemma.
    Miller MA; Church LW; Salgado CD
    Am J Med Sci; 2008 Oct; 336(4):358-61. PubMed ID: 18854683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoblotting using Strongyloides venezuelensis larvae, parthenogenetic females or eggs extracts for the diagnosis of experimentally infected immunosuppressed rats.
    Goulart de Carvalho EF; Neto de Sousa JE; Gonçalves AL; da Cunha-Junior JP; Costa-Cruz JM
    Exp Parasitol; 2015 Oct; 157():117-23. PubMed ID: 26219202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific IgG and immune complex responses to parthenogenetic females and eggs of nematode Strongyloides venezuelensis for the diagnosis of immunosuppression in infected rats.
    Gonçalves AL; de Araújo KC; Carvalho EF; Ueta MT; Costa-Cruz JM
    J Helminthol; 2016 May; 90(3):342-6. PubMed ID: 25997825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with nitric oxide donors diminishes hyperinfection by Strongyloides venezuelensis in mice treated with dexamethasone.
    Ruano AL; López-Abán J; Fernández-Soto P; de Melo AL; Muro A
    Acta Trop; 2015 Dec; 152():90-95. PubMed ID: 26342794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of thiabendazole, mebendazole and cambendazole in normal and immunosuppressed dogs infected with a human strain of Strongyloides stercoralis.
    Grove DI; Northern C
    Trans R Soc Trop Med Hyg; 1988; 82(1):146-9. PubMed ID: 3176142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new faecal antigen detection system for Strongyloides venezuelensis diagnosis in immunosuppressed rats.
    Gonçalves AL; Silva CV; Ueta MT; Costa-Cruz JM
    Exp Parasitol; 2010 Aug; 125(4):338-41. PubMed ID: 20206167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephrotic syndrome in strongyloidiasis: remission after eradication with anthelmintic agents.
    Wong TY; Szeto CC; Lai FF; Mak CK; Li PK
    Nephron; 1998; 79(3):333-6. PubMed ID: 9678435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strongyloides hyperinfection syndrome after intestinal transplantation.
    Patel G; Arvelakis A; Sauter BV; Gondolesi GE; Caplivski D; Huprikar S
    Transpl Infect Dis; 2008 Apr; 10(2):137-41. PubMed ID: 17605735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent eosinophilia and Strongyloides infection in Montagnard refugees after presumptive albendazole therapy.
    Goswami ND; Shah JJ; Corey GR; Stout JE
    Am J Trop Med Hyg; 2009 Aug; 81(2):302-4. PubMed ID: 19635888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strongyloides as a cause of fever of unknown origin.
    Neumann I; Ritter R; Mounsey A
    J Am Board Fam Med; 2012; 25(3):390-3. PubMed ID: 22570402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of parasitological, immunological and molecular methods for evaluation of fecal samples of immunosuppressed rats experimentally infected with Strongyloides venezuelensis.
    Chaves LA; Gonçalves AL; Paula FM; Silva NM; Silva CV; Costa-Cruz JM; Freitas MA
    Parasitology; 2015 Dec; 142(14):1715-21. PubMed ID: 26442899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Systemic strongyloidiasis. Hyperinfection syndrome and disseminated strongyloidiasis].
    Hagelskjaer LH
    Ugeskr Laeger; 1993 Aug; 155(35):2715-6. PubMed ID: 8212390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disseminated strongyloidiasis. A complication of the immunosuppressed host.
    Kuberski TT; Gabor EP; Boudreaux D
    West J Med; 1975 Jun; 122(6):504-8. PubMed ID: 1056115
    [No Abstract]   [Full Text] [Related]  

  • 16. Fatal relapse of disseminated strongyloidiasis in an HIV-positive patient, despite ivermectin treatment.
    Mattioni S; Valin N; Cracco C; Thellier M; Danis M; Caumes E
    Ann Trop Med Parasitol; 2008 Dec; 102(8):693-8. PubMed ID: 19000386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disseminated strongyloidiasis: report of seven cases.
    Leelarasamee A; Nimmannit S; Na Nakorn S; Aswapokee N; Aswapokee P; Benjasuratwong Y
    Southeast Asian J Trop Med Public Health; 1978 Dec; 9(4):539-42. PubMed ID: 751221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of albendazole against Strongyloides ratti and S. stercoralis in vitro, in mice, and in normal and immunosuppressed dogs.
    Grove DI; Lumsden J; Northern C
    J Antimicrob Chemother; 1988 Jan; 21(1):75-84. PubMed ID: 3356624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the therapeutic activity of albendazole in rats experimentally infected with Strongyloides venezuelensis].
    Amato Neto V; Pinto PL; Moreira AA; Campos R; de Sant'Ana EJ; Levai EV; Padilha LA; Takiguti CK
    Rev Inst Med Trop Sao Paulo; 1986; 28(3):181-4. PubMed ID: 3823741
    [No Abstract]   [Full Text] [Related]  

  • 20. Disseminated Strongyloides stercoralis infection with a cutaneous presentation in an immunosuppressed patient.
    Benvenuti F; Carrascosa JM; Boada A; Ferrandiz C
    Eur J Dermatol; 2009; 19(4):404-5. PubMed ID: 19467975
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.